Comorbid elevated symptoms of anxiety and depression in adults with type 1 or type 2 diabetes

Results from the International Diabetes MILES Study

Giesje Nefs, Christel Hendrieckx, Prasuna Reddy, Jessica L Browne, Mariska Bot, John Dixon, Michael Kyrios, Jane Speight, François Pouwer

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Resumé

AIMS: We examined: (a) the prevalence of comorbid elevated symptoms of anxiety/depression; (b) its demographic/clinical correlates; (c) associations with self-care behaviors, by diabetes type.

METHODS: Cross-sectional self-report data of 6590 adults with diabetes (42% type 1; 58% type 2) from the Australian and Dutch Diabetes MILES studies were used. Elevated symptoms of anxiety/depression were defined as GAD-7 ≥ 10/PHQ-9 ≥ 10.

RESULTS: In both diabetes types, comorbid elevated symptoms of anxiety/depression were present in 9% and symptoms of anxiety alone in 2%; symptoms of depression alone were present in 8% of adults with type 1 diabetes and 11% with type 2 diabetes. Shorter diabetes duration (type 1 only) was the only characteristic that distinguished those with comorbid elevated symptoms of anxiety/depression but not those with symptoms of anxiety/depression alone from the reference group (no/minimal symptoms of anxiety/depression). Those with comorbid elevated symptoms of anxiety/depression had increased odds of sub-optimal diabetes self-care behaviors compared with the reference group, with higher odds than those with symptoms of anxiety or depression alone.

CONCLUSIONS: Comorbid elevated symptoms of anxiety/depression affected one in ten respondents, who also had increased odds of suboptimal diabetes self-care. Those with shorter type 1 diabetes duration may be at increased risk.

OriginalsprogEngelsk
TidsskriftJournal of Diabetes and its Complications
Vol/bind33
Udgave nummer8
Sider (fra-til)523-529
ISSN1056-8727
DOI
StatusUdgivet - aug. 2019

Fingeraftryk

Type 2 Diabetes Mellitus
Depression
Self Report

Citer dette

Nefs, Giesje ; Hendrieckx, Christel ; Reddy, Prasuna ; Browne, Jessica L ; Bot, Mariska ; Dixon, John ; Kyrios, Michael ; Speight, Jane ; Pouwer, François. / Comorbid elevated symptoms of anxiety and depression in adults with type 1 or type 2 diabetes : Results from the International Diabetes MILES Study. I: Journal of Diabetes and its Complications. 2019 ; Bind 33, Nr. 8. s. 523-529.
@article{04ab8c3bfa1441c887c44cce090e8888,
title = "Comorbid elevated symptoms of anxiety and depression in adults with type 1 or type 2 diabetes: Results from the International Diabetes MILES Study",
abstract = "AIMS: We examined: (a) the prevalence of comorbid elevated symptoms of anxiety/depression; (b) its demographic/clinical correlates; (c) associations with self-care behaviors, by diabetes type.METHODS: Cross-sectional self-report data of 6590 adults with diabetes (42{\%} type 1; 58{\%} type 2) from the Australian and Dutch Diabetes MILES studies were used. Elevated symptoms of anxiety/depression were defined as GAD-7 ≥ 10/PHQ-9 ≥ 10.RESULTS: In both diabetes types, comorbid elevated symptoms of anxiety/depression were present in 9{\%} and symptoms of anxiety alone in 2{\%}; symptoms of depression alone were present in 8{\%} of adults with type 1 diabetes and 11{\%} with type 2 diabetes. Shorter diabetes duration (type 1 only) was the only characteristic that distinguished those with comorbid elevated symptoms of anxiety/depression but not those with symptoms of anxiety/depression alone from the reference group (no/minimal symptoms of anxiety/depression). Those with comorbid elevated symptoms of anxiety/depression had increased odds of sub-optimal diabetes self-care behaviors compared with the reference group, with higher odds than those with symptoms of anxiety or depression alone.CONCLUSIONS: Comorbid elevated symptoms of anxiety/depression affected one in ten respondents, who also had increased odds of suboptimal diabetes self-care. Those with shorter type 1 diabetes duration may be at increased risk.",
keywords = "Anxiety, Comorbidity, Depression, Health behavior, Self-care",
author = "Giesje Nefs and Christel Hendrieckx and Prasuna Reddy and Browne, {Jessica L} and Mariska Bot and John Dixon and Michael Kyrios and Jane Speight and Fran{\cc}ois Pouwer",
year = "2019",
month = "8",
doi = "10.1016/j.jdiacomp.2019.04.013",
language = "English",
volume = "33",
pages = "523--529",
journal = "Journal of Diabetes and its Complications",
issn = "1056-8727",
publisher = "Elsevier",
number = "8",

}

Comorbid elevated symptoms of anxiety and depression in adults with type 1 or type 2 diabetes : Results from the International Diabetes MILES Study. / Nefs, Giesje; Hendrieckx, Christel; Reddy, Prasuna; Browne, Jessica L; Bot, Mariska; Dixon, John; Kyrios, Michael; Speight, Jane; Pouwer, François.

I: Journal of Diabetes and its Complications, Bind 33, Nr. 8, 08.2019, s. 523-529.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - Comorbid elevated symptoms of anxiety and depression in adults with type 1 or type 2 diabetes

T2 - Results from the International Diabetes MILES Study

AU - Nefs, Giesje

AU - Hendrieckx, Christel

AU - Reddy, Prasuna

AU - Browne, Jessica L

AU - Bot, Mariska

AU - Dixon, John

AU - Kyrios, Michael

AU - Speight, Jane

AU - Pouwer, François

PY - 2019/8

Y1 - 2019/8

N2 - AIMS: We examined: (a) the prevalence of comorbid elevated symptoms of anxiety/depression; (b) its demographic/clinical correlates; (c) associations with self-care behaviors, by diabetes type.METHODS: Cross-sectional self-report data of 6590 adults with diabetes (42% type 1; 58% type 2) from the Australian and Dutch Diabetes MILES studies were used. Elevated symptoms of anxiety/depression were defined as GAD-7 ≥ 10/PHQ-9 ≥ 10.RESULTS: In both diabetes types, comorbid elevated symptoms of anxiety/depression were present in 9% and symptoms of anxiety alone in 2%; symptoms of depression alone were present in 8% of adults with type 1 diabetes and 11% with type 2 diabetes. Shorter diabetes duration (type 1 only) was the only characteristic that distinguished those with comorbid elevated symptoms of anxiety/depression but not those with symptoms of anxiety/depression alone from the reference group (no/minimal symptoms of anxiety/depression). Those with comorbid elevated symptoms of anxiety/depression had increased odds of sub-optimal diabetes self-care behaviors compared with the reference group, with higher odds than those with symptoms of anxiety or depression alone.CONCLUSIONS: Comorbid elevated symptoms of anxiety/depression affected one in ten respondents, who also had increased odds of suboptimal diabetes self-care. Those with shorter type 1 diabetes duration may be at increased risk.

AB - AIMS: We examined: (a) the prevalence of comorbid elevated symptoms of anxiety/depression; (b) its demographic/clinical correlates; (c) associations with self-care behaviors, by diabetes type.METHODS: Cross-sectional self-report data of 6590 adults with diabetes (42% type 1; 58% type 2) from the Australian and Dutch Diabetes MILES studies were used. Elevated symptoms of anxiety/depression were defined as GAD-7 ≥ 10/PHQ-9 ≥ 10.RESULTS: In both diabetes types, comorbid elevated symptoms of anxiety/depression were present in 9% and symptoms of anxiety alone in 2%; symptoms of depression alone were present in 8% of adults with type 1 diabetes and 11% with type 2 diabetes. Shorter diabetes duration (type 1 only) was the only characteristic that distinguished those with comorbid elevated symptoms of anxiety/depression but not those with symptoms of anxiety/depression alone from the reference group (no/minimal symptoms of anxiety/depression). Those with comorbid elevated symptoms of anxiety/depression had increased odds of sub-optimal diabetes self-care behaviors compared with the reference group, with higher odds than those with symptoms of anxiety or depression alone.CONCLUSIONS: Comorbid elevated symptoms of anxiety/depression affected one in ten respondents, who also had increased odds of suboptimal diabetes self-care. Those with shorter type 1 diabetes duration may be at increased risk.

KW - Anxiety

KW - Comorbidity

KW - Depression

KW - Health behavior

KW - Self-care

U2 - 10.1016/j.jdiacomp.2019.04.013

DO - 10.1016/j.jdiacomp.2019.04.013

M3 - Journal article

VL - 33

SP - 523

EP - 529

JO - Journal of Diabetes and its Complications

JF - Journal of Diabetes and its Complications

SN - 1056-8727

IS - 8

ER -